Teladoc Health reported Q2 2026 revenue of $607 million, missing consensus estimates and posting a 4% year-over-year decline, while adjusted EPS loss beat expectations at $0.21; the stock fell about 16% after hours.

Integrated Care revenue grew 1% year over year to $394.3 million, signaling a shift in mix toward insurance-covered services.

BetterHelp paying users totaled 0.35 million, short of the four-analyst average of 0.37 million, underscoring cash-pay headwinds.

Teladoc emphasized cash flow strength, continuing a pattern of free cash flow generation and a cash-focused view of profitability.

Management described mixed dynamics: solid Integrated Care performance but ongoing near-term challenges in BetterHelp due to cash-pay revenue pressure and limited capacity for insurance-reimbursed services.

Strategic shift prioritizes accelerating U.S. insurance-based rollout for BetterHelp over international markets, framed as a prioritization rather than an exit.

CEO Chuck Divita highlighted progress, including the launch of Teladoc One and a new connected care model during the quarter.

Chronic Care Program enrollment rose 13.9% year over year to 1,272,000, with 1.27 million enrolled—above the two-analyst average.

Free cash flow guidance remained unchanged at $130 million to $170 million for the year.

Peer context shows consumer internet peers delivering mixed results, with market reactions varying and Teladoc trading in a cautious environment.

Teladoc’s stock closed at about $9.18, reflecting a notable rally over the past quarter though still pressured by the earnings miss.

Market capitalization stood around $1.69 billion following the results, with management citing progress across two core segments.